European Commission 12 November 2026, Commission Implementing Regulation (EU) 2026/2506 of 12 November 2026 cancelling the Union authorisation for the single biocidal product Superficid express in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council and repealing Commission Implementing Regulation (EU) 2023/1133
Also known as
European Union · · · 12-11-2026
Official Journal
of the European Union
EN
L series
2026/2506
13.11.2026
COMMISSION IMPLEMENTING REGULATION (EU) 2026/2506
of 12 November 2026
cancelling the Union authorisation for the single biocidal product ‘Superficid express’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council and repealing Commission Implementing Regulation (EU) 2023/1133
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (1), and in particular Article 49 thereof,
Whereas:
(1)
On 8 June 2023, Commission Implementing Regulation (EU) 2023/1133 (2) granted a Union authorisation with the authorisation number EU-0027677-0000 to the authorisation holder Lysoform Dr. Hans Rosemann GmbH for the making available on the market and use of the same single biocidal product containing Propan-1-ol and Propan-2-ol ‘Superficid express’ in accordance with Article 44(5), first subparagraph, of Regulation (EU) No 528/2012.
(2)
On 23 July 2026, Lysoform Dr. Hans Rosemann GmbH submitted to the European Chemicals Agency (‘the Agency’) a request to cancel that Union authorisation in accordance with Article 49 of Regulation (EU) No 528/2012. The request was recorded under case number BC-AP120147-45 in the Register for Biocidal Products.
(3)
On 15 September 2026, Lysoform Dr. Hans Rosemann GmbH submitted a reasoning for the request for cancellation, providing that it had decided to discontinue the production of ‘Superficid express’ based on commercial considerations.
(4)
On 16 September 2026, the Agency forwarded the reasoned request to the Commission.
(5)
It is therefore appropriate to cancel the Union authorisation for the single biocidal product ‘Superficid express’ at the reasoned request of the authorisation holder and
Read the full text
This document is published by eur-lex.europa.eu.
Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.
Sign in to Moonlit